相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome
Mojca Jensterle et al.
ENDOCRINE RESEARCH (2015)
Ensembl 2015
Fiona Cunningham et al.
NUCLEIC ACIDS RESEARCH (2015)
Role of the rs6923761 Gene Variant in Glucagon-Like Peptide 1 Receptor Gene on Cardiovascular Risk Factors and Weight Loss after Biliopancreatic Diversion Surgery
Daniel Antonio de Luis et al.
ANNALS OF NUTRITION AND METABOLISM (2014)
Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease
H. Kahal et al.
CLINICAL ENDOCRINOLOGY (2014)
Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
Mojca Jensterle Sever et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults
M. E. J. Lean et al.
INTERNATIONAL JOURNAL OF OBESITY (2014)
Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS
L. van Bloemendaal et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Prediction of response to GLP-1 receptor agonist therapy in Japanese patients with type 2 diabetes
Kenjiro Imai et al.
DIABETOLOGY & METABOLIC SYNDROME (2014)
The effect of liraglutide on weight loss in women with polycystic ovary syndrome: an observational study
Christina B. Rasmussen et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme
K. Niswender et al.
DIABETES OBESITY & METABOLISM (2013)
Minireview: Signal Bias, Allosterism, and Polymorphic Variation at the GLP-1R: Implications for Drug Discovery
Cassandra Koole et al.
MOLECULAR ENDOCRINOLOGY (2013)
Glucagon-like peptide 1 and appetite
Megan J. Dailey et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
The central GLP-1: implications for food and drug reward
Karolina P. Skibicka
FRONTIERS IN NEUROSCIENCE (2013)
The structure and function of the glucagon-like peptide-1 receptor and its ligands
Dan Donnelly
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis
S. S. Lim et al.
HUMAN REPRODUCTION UPDATE (2012)
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
A. Astrup et al.
INTERNATIONAL JOURNAL OF OBESITY (2012)
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
Juris J. Meier
NATURE REVIEWS ENDOCRINOLOGY (2012)
The influence of gemcitabine pathway polymorphisms on treatment outcome in patients with malignant mesothelioma
Nina Erculj et al.
PHARMACOGENETICS AND GENOMICS (2012)
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials
Tina Vilsboll et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Third intracellular loop of glucagon like-peptide-1 receptor is coupled with endogenous mono-ADP-ribosyltransferase - Novel type of receptor regulation?
Matjaz Dezelak et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Common Genetic Variation in GLP1R and Insulin Secretion in Response to Exogenous GLP-1 in Nondiabetic Subjects A pilot study
Airani Sathananthan et al.
DIABETES CARE (2010)
Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome
Karen Elkind-Hirsch et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies
D. A. Tregouet et al.
BIOINFORMATICS (2007)
Different role of intracellular loops of glucagon-like peptide-1 receptor in G-protein coupling
A Bavec et al.
REGULATORY PEPTIDES (2003)
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
J Tuomilehto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
dbSNP: the NCBI database of genetic variation
ST Sherry et al.
NUCLEIC ACIDS RESEARCH (2001)
The use of single-nucleotide polymorphism maps in pharmacogenomics
JJ McCarthy et al.
NATURE BIOTECHNOLOGY (2000)